← brief for 2026-09-24 · Slowing decline

Rare Hereditary Cardiac Amyloidosis Treated With SGLT2 Inhibitor: Beyond ATTR/AL.

Key takeaways

This report describes one man with a rare heart condition called cardiac amyloidosis. He also had kidney disease. Doctors treated him with an SGLT2 inhibitor, a drug often used for diabetes and heart failure. The report shares his story but does not prove the drug works for everyone with this condition.

Who did this work

Voran JC · Radić Ž · Kilian LS · Braun F · Röcken C · Frank D · Seoudy H

Source

Article · PubMed, the drug frontier · 2026 Sep 23
https://pubmed.ncbi.nlm.nih.gov/42782028/